US futures sank on the morning of October 22: Nasdaq 100 futures fell about 1.6%, S&P 500 futures about 1.0%, while Brent moved above $112. The Reuters flow flags two drivers behind the slide: Iran headlines plus large technology prints that failed to calm funding fears around AI buildouts. A Yahoo Finance note on the October 20 close shows the setup was not new: indexes steadied intraday, yet technology stocks stayed under pressure.
The earnings season lit the fuse. META opened lower despite ad revenue above expectations, while a lowered end-of-decade sales target on the Tesla side hurt morale. The CNBC trading-day note names the pressure point openly: quarterly free cash turned negative and the lower end of the yearly capex plan moved up. The market question shifted: profit grows, but when does cash left for holders grow?
Why stocks shook: oil and the AI bill
Behind the move sits a swelling AI facilities check. A Bloomberg roundup puts future commitments from the largest technology firms near $2.4T; a WSJ analysis finds the picture runs $3T above what headline capex shows once off-balance-sheet leases and supply obligations join in. Commitments at this scale travel fine while outside funding flows; once flows stall, the load lands first on orders, then across the supply chain. That is why the selloff cannot be read through earnings prints alone.
Funding is therefore the hinge. Where a narrow set of customers rents AI capacity on outside money, order flow can slow while rates stay high and the listings window stays shut. Softness shows first across cloud and software layers, then among component makers. As the market watches that chain, it chases tomorrow payment power rather than today demand; multiples alone stop persuading.
META: strong ads, squeezed cash print
The META ad engine runs hot. The company disclosure at atmeta.com puts third-quarter revenue at $64.6B, up 26% on last year; ad revenue hit $63.1B, impressions rose 10%, average ad pricing gained 14%. Daily users grew 3% to 3.64B while revenue per user climbed about 23%. The US and Canada region stayed the strongest at $26.2B. The picture shows buildout funding drawn from a solid ad register.
The same disclosure writes the cash squeeze openly. Operating cash of $32.8B met $33.9B of equipment buying plus lease payments, leaving free cash at -$2.1B. CNBC carried that negative balance as the headline of the day: the market hunts cash left in the register, not profit. The yearly capex frame narrowed to $135-145B; with $85.8B used over nine months, about $49-59B of load waits in the final quarter. The ad register fills while facilities drain it at matching speed.
Valuation reads tense but workable. Near a $690 quote the forward earnings multiple sits around 22, close to its own history, so a large discount is hard to claim. The framework here points to about $809 of value, 17% upside with a 15% safety margin, built on a 9% discount rate with three quarters of value rooted in terminal years. Ad growth of 26% earns attention; yet while facility outlays keep pressing register cash, the multiple alone cannot justify buying.
LRCX and NVDA face the valuation test
LRCX fell hard: shares slid 7-8% in one morning. The Yahoo Finance readout puts September-quarter revenue at $8.22B, up 22% sequentially, with adjusted earnings of $2.20 ahead of consensus. Yet the December guide of $8.6B plus or minus $0.4B brought no relief: supply-chain limits push shipments later, and the China share drops clearly from the 35% level. The market prices the next two quarters of delivery calendars, not the record quarter.
The valuation scenario here carries the quote toward about $300 of value; against $240 that means 25% upside with a 20% safety margin. But the arithmetic needs free cash to double from about $4.9B toward $10B, then grow 15% yearly under a 9% discount rate. The highest percentage in this file rides on the harshest cash assumption. Holding it on a watchlist beats adding weight before delivery evidence arrives.
NVDA starts from firmer ground: shares traded near $217 in the morning, up 19% since the start of 2026. Revenue growth runs above 80%, gross margin near 75%, operating margin near 65%. Analyst estimates sit near $9.31 for the year ending January 2027 and near $16 for the next year, mapping to multiples of 23 and 14. Reuters relays that strong sales growth is penciled in for next year; should forecasts revise lower, the apparent cheapness evaporates fast.
The NVDA framework yields $255 of value, 18% upside with a 15% safety margin, assuming free cash walks from about $150B in 2027 toward $250B in 2030, then grows 15%, discounted at 9%. The company itself holds net cash on the cost side; risk sits with buyer funding. Current profitability offers the firmest floor for that assumption load, so NVDA takes first place for a gradual start. Missed forecasts would still erode the multiple edge quickly.
Ranking plus lines to watch
NVDA ranks first among the three stocks: existing profit and cash generation carry assumption load most comfortably. META comes next: ads grow 26%, yet anything beyond a small conditional start looks hard before cash recovery shows proof. LRCX stays on watch in third: the top percentage lives here, but the one-year cash doubling is the toughest call. The main lesson of this ranking is that the largest upside never converts into first place by itself.
Three lines deserve watching next quarter: whether META fourth-quarter capex lands inside the $49-59B band, how LRCX deliveries and the China mix track the guide, and which way NVDA forecast revisions point. Cheaper quotes after a rout alone justify nothing; cash conversion must reach earnings per share. Brent direction and the rate path belong to the picture too; NBCNews intraday selloff analysis frames the Iran headline and oil quotes together. This content is not investment advice; consult a specialist before deciding.
Key moments
AI commentary
"What stayed with me while preparing this file is why solid prints offered no shelter on a selloff day. META runs a genuinely strong ad engine, with volume and pricing rising together in one quarter. Yet the cash math is blunt: $32.8B came in from operations while $34.9B went out to equipment, leaving free cash negative. Calling that temporary is easy, but with a $135-145B yearly plan the fourth-quarter load is visible. LRCX flips the story: the price fell much faster, yet the cash doubling inside its valuation is the harsher assumption. I put NVDA first for no excitement reason; it holds the current profitability that can carry assumption load. Still, all three frameworks rest on a 9% discount rate with distant years doing heavy lifting; missed forecasts change outcomes fast. So read this file as a monitoring frame, not a shopping list."
AI assessment
META revenue and cash prints check against the company disclosure at atmeta.com: $64.6B revenue, -$2.1B free cash, a $135-145B yearly plan; the CNBC negative-cash report tells the same story.
The LRCX guide checks against the Yahoo Finance readout: an $8.6B plus-or-minus $0.4B December bar, supply limits, a falling China share; September-quarter $8.22B revenue and $2.20 earnings match the same source.
The selloff frame matches Reuters: Nasdaq 100 futures down 1.6% with Brent above $112; the Iran headline and oil linkage runs the same direction in NBCNews analysis.
Valuation outputs ($809, $300, $255) are scenario math; the 9% discount rate, cash doubling and terminal-year weight rest on assumptions, unverified by independent sources.
This content is for information only and is not investment advice; consult a licensed professional before making investment decisions.
Sources
9 links; 1 of them also cited by 1 other story. Stories sharing a link do not confirm each other; a source's origin is not inferred from how often it is cited.
stocks · earnings · valuation · nasdaq · investment · brent · cash